Contraline’s ADAM system, a non-hormonal contraception for males, has completed 24 months of successful trials as a safe and effective new alternative to traditional birth control methods.
Contraline have previously mentioned that the ADAM contraceptive proved to be safe and effective after 24 months of trials, paving the way for it to be a practical alternative to existing methods of birth control.
For years, contraceptive options have mainly focused on women, making ADAM a step forward in reproductive health.
A Breakthrough for Male Birth Control
ADAM male contraceptive is a water-soluble hydrogel injected into the vasa deferentia – tubes carrying sperm from the testicles to the urethra. The minimally invasive procedure prevents sperm from going to the urethra but not ejaculating, making ADAM a potential long acting and reversible means for men seeking a contraceptive option other than condoms or vasectomies.
“Our goal was to create a male contraceptive option lasting two years, responding directly to consumer needs, these findings confirm that ADAM, our novel water-soluble hydrogel, can achieve the intended lifespan. We remain optimistic about its safety, efficacy, and reversibility, and its potential to give men and couples greater reproductive control,” Alexander Pastuszak, Contraline’s Chief Medical Officer, said in the release.
Two of the non-hormonal contraception trial volunteers have been diagnosed with azoospermia (the absence of sperm in their ejaculate) at 24 months, and the company previously released a 99.8% to 100% reduction in sperm motility within 30 days of the implant.
https://twitter.com/signorina_AG/status/1916946751074013370/photo/1
Contraline expects these results to change the course of the future of contraception by providing men with an easy, long-term alternative.
Injectable Male Contraceptive
Despite the encouraging outcomes, arguments surfaced around male contraceptive injection side effects, even though no harmful side effects have been reported during the trial, issues concerning long-term effects as well as reversibility of the implant remain.
Washington State University professor, Jon Oatley, was reserved in his reaction, highlighting that information concerning ADAM’s reversibility is still required. Oatley further added that several men might want a less invasive form of contraception like a pill or patch rather than the male contraceptive injection.
If ADAM non-hormonal contraception stays on the same pace, it may end in the same league as long-acting reversible contraceptives such as IUDs, which have gained popularity among women in recent years.
Contraline could provide men with new types of male contraceptives options with further trials and regulatory approval. If successful, the contraceptive injection could become one of the most popular options among couples for reliable, non-hormonal contraception soon.
While the contraceptive side effects have been low to this point, ongoing testing will continue to monitor to identify any potential effect, including ADAM male contraceptive injection side effects. If results continue to be positive, men will enjoy a new tool in family planning, giving them an alternative method of non-hormonal contraception to long-acting female birth control.
Inside Telecom provides you with an extensive list of content covering all aspects of the Tech industry. Keep an eye on our Medtech section to stay informed and updated with our daily articles.